All data are based on the daily closing price as of June 6, 2025
s
Seegene
096530.KQ
23.83 USD
-0.23
-0.96%
Overview
Last close
23.83 usd
Market cap
1.10B usd
52 week high
25.43 usd
52 week low
14.21 usd
Target price
31.64 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.395
Price/Book Value
1.4908
Enterprise Value
789.54M usd
EV/Revenue
2.4372
EV/EBITDA
11.3413
Key financials
Revenue TTM
323.95M usd
Gross Profit TTM
196.04M usd
EBITDA TTM
61.88M usd
Earnings per Share
N/A usd
Dividend
0.59 usd
Total assets
839.36M usd
Net debt
N/A usd
About
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.